Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/22/2010CN101148462B Azithromycin derivative and application thereof
12/22/2010CN101148461B Azithromycin derivative and application thereof
12/22/2010CN101125130B Indian chrysanthemum effervescent preparation and preparation method thereof
12/22/2010CN101120911B Ftibamzone chrisma with propanediol as co-solvent
12/22/2010CN101119976B HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
12/22/2010CN101095951B Therapeutic HBV DNA vaccines, method for preparing the same and application thereof
12/21/2010US7855277 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010US7855197 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
12/21/2010US7855066 the ions include zinc and cobalt which improve Apo-2 ligand trimer formation and stability; tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
12/21/2010US7854937 Flavivirus fusion inhibitors
12/21/2010CA2492718C Prodrugs of proton pump inhibitors
12/21/2010CA2470109C Substituted phenyl naphthalenes as estrogenic agents
12/21/2010CA2444130C Adenine derivatives
12/21/2010CA2441386C Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
12/21/2010CA2434337C Combination of probiotics
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2387182C Lentiviral vectors for the preparation of immunotherapeutical compositions
12/21/2010CA2322215C Matrix protein compositions for wound healing
12/21/2010CA2260273C Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
12/21/2010CA2214406C Use of penciclovir for the treatment of human herpes-virus-8
12/16/2010WO2010144908A2 Mammalian genes involved in tularemia and other infections
12/16/2010WO2010144386A2 Antimicrobial polymers
12/16/2010WO2010144348A2 Reduction of antibiotic activity or concentration in biological samples using molecularly imprinted polymers
12/16/2010WO2010144231A2 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/16/2010WO2010143171A1 Pharmaceutical composition contains parasite plant and saurauja nudiflora d. c.
12/16/2010WO2010143158A1 Oxazole and thiazole derivatives as alx receptor agonists
12/16/2010WO2010142978A1 Heterocyclic urea derivatives and methods of use thereof
12/16/2010WO2010142779A1 Antifungal 1,2,4-triazolyl derivatives having a 5- sulfur substituent
12/16/2010WO2010142761A1 The succinate of tenofovir disoproxil
12/16/2010WO2010142656A1 Heterocyclic antiviral compounds
12/16/2010WO2010142630A1 Il-17 for use in treating local infections in mammals
12/16/2010WO2010142241A1 High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
12/16/2010WO2010142124A1 New uses of medicines with adamantane structure and their derivatives and analogues in treating tumor-related diseases
12/16/2010WO2010142030A1 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
12/16/2010WO2010142027A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010WO2010142017A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
12/16/2010WO2010091124A3 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
12/16/2010WO2010086867A3 Peptides, pharmaceutical compositions comprising same and uses thereof
12/16/2010WO2010055474A3 Antimicrobial compounds and compositions
12/16/2010WO2010041241A3 Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding
12/16/2010US20100318040 Catheter Locking Solution Having Antimicrobial and Anticoagulation Properties
12/16/2010US20100317734 Free fatty acid blends and use thereof
12/16/2010US20100317724 Method for searching for homing endonucleases, their genes and their targets
12/16/2010US20100317707 Oligomer-Nitroimidazole Anti-Infective Conjugates
12/16/2010US20100317706 HNF4alpha MODULATORS AND METHODS OF USE
12/16/2010US20100317696 Iminosugars and methods of treating bunyaviral and togaviral diseases
12/16/2010US20100317695 Gel composition for treating mycosis
12/16/2010US20100317684 Amide and Carbamate Derivatives of N-{2-[4-Amino-2- (Ethoxymethyl)-1H-Imidazo[4,5-c] Quinolin-1-Yl]-1,1-Dimethylethyl} Methanesulfonamide and Methods
12/16/2010US20100317678 Hydroxamates as inhibitors of histone deacetylase
12/16/2010US20100317677 Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317637 Anti-hepatitis c composition and method for preparing drug for inhibiting hepatitis c viruses or treating hepatitis c
12/16/2010US20100317634 Piperidyl-propane-thiol ccr3 modulators
12/16/2010US20100317629 Dissolvable pharmaceutical implant
12/16/2010US20100317627 Treatment of HCV Disorders
12/16/2010US20100317625 Novel sulfonamidomethylphosphonate inhibitors of beta-lactamase
12/16/2010US20100317624 Heterocyclic urea derivatives and methods of use thereof
12/16/2010US20100317623 HCV NS3 Protease Inhibitors
12/16/2010US20100317621 Beta-lactamase inhibitors
12/16/2010US20100317607 Use of compounds for preparing anti-tuberculosis agents
12/16/2010US20100317604 Forsythiaside injection preparation and preparative method thereof
12/16/2010US20100317601 Casein Derived Peptides And Uses Thereof
12/16/2010US20100317568 Anti-Viral Compounds
12/16/2010US20100317567 Diagnosing and protecting horses against papillomavirus
12/16/2010US20100317566 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/16/2010US20100317519 Mixtures and methods for the induction of resistance in plants
12/16/2010US20100317518 Meadowfoam-based bioherbicide products
12/16/2010US20100316737 Homeopathic complex
12/16/2010US20100316726 Tooth sealant
12/16/2010US20100316716 Method for treating herpes zoster lesions
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316704 Platinum complexes and methods of use
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316699 Compositions and Methods for Inhibiting Viral Replication
12/16/2010US20100316698 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/16/2010US20100316697 Methods and compositions for drug targeting
12/16/2010US20100316695 Condensation products based on bicyclic or polycyclic aromatics or heteroaromatics
12/16/2010US20100316693 Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton prepared therefrom
12/16/2010US20100316691 Biodegradable intravaginal medical device for delivery of therapeutics
12/16/2010US20100316685 Dental Uses of Silver Hydrosol
12/16/2010US20100316681 N-alkylated rifampin
12/16/2010US20100316676 Bisphosphonate Compounds and Methods for Bone Resorption Diseases, Cancer, Bone Pain, Immune Disorders, and Infectious Diseases
12/16/2010US20100316675 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
12/16/2010US20100316674 Immunogenic compositions against tuberculosis
12/16/2010US20100316673 Nanoemulsion vaccines
12/16/2010US20100316672 Vaccine
12/16/2010US20100316671 Monoparamunity inducers based on attenuated rabbit myxomaviruses
12/16/2010US20100316670 Chimeric sle/dengue type 4 antigenic viruses
12/16/2010US20100316669 Vaccine formulation potentiated by the combination of dna and an antigen
12/16/2010US20100316666 Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
12/16/2010US20100316665 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
12/16/2010US20100316663 Subunit Vaccine for Aquaculture
12/16/2010US20100316662 Methods and Compositions for Vaccination Comprising Nucleic Acid and/or Polypeptide Sequences of Chlamydia
12/16/2010US20100316654 Neutralizing antibodies to influenza viruses
12/16/2010US20100316647 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy
12/16/2010US20100316643 Targeted antimicrobial moieties
12/16/2010US20100316641 Engineered antibody constant domain molecules
12/16/2010US20100316610 Mutant having uracil phosphoribosyl transferase activity
12/16/2010US20100316608 Method of Determining A Response To Treatment With Immunomodulatory Composition
1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 1798